Summary Of Covid-19 Mrna Vaccine (Nucleoside-Modified)-Api-Biologics & Biosimilars

Chemical Name

Covid-19 Mrna Vaccine (Nucleoside-Modified)

CAS No.

7654-32-1

Molecular Formula

--

Innovator

Developer

Indication

--

Therapeutic Area

--

Market Status

--

Approval Year

Patent Expiry